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1991-7902/Copyrightª 2015, AssociatioAbstract Background/purpose: Inducing human-periodontal-ligament-stem-cell (hPDLSC)
differentiation by DNA transfection is a promising way for periodontal tissue engineering. How-
ever, there are only a few studies that focus on the introduction of foreign DNA into hPDLSCs by
nonviral methods that are relatively safe. Hence, the major purposes of this study were to
compare the transfection efficiency and toxicity of nonviral-gene-transfer methods on
hPDLSCs, and to search for the best approach and optimal protocol for transferring genes into
hPDLSCs using nonviral vectors.
Materials and methods: The hPDLSCs were transfected by (1) Lipofectamine 2000, (2) poly-
ethylenimine, (3) GBfectene-Elite transfection reagent, (4) X-tremeGENE HP DNA Transfection
Reagent, and (5) Magnet-Assisted Transfection (MATra), compared to (6) lentiviral vectors
harboring a green-fluorescent-protein gene. The transfection efficiency was measured by a
fluorescence microscope and flow cytometry. Meanwhile, the cell morphology and growth sta-
tus were observed to estimate the cytotoxicity.
Results: Among these methods, the transfection efficiency of the former four methods was not
very satisfactory (< 6%) compared to that of lentiviral vectors (positive control, 95%). Howev-
er, MATra was the most effective nonviral method (11%). Moreover, the cellular toxicity was
lower than that of the former four methods.
Conclusion: The transfection efficiency of hPDLSCs with MATra was higher than the other
nonviral transfection reagents in this study, but it was far less than the viral vectors. Saving
from the interaction between the positive and negative charges, and increasing thet of Periodontology, School and Hospital of Stomatology, Wuhan University, 237 Luo Yu Road, Wuhan
.com (S. Shang), lcz56@163.com (C. Li).
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Various nonviral vectors for transfecting hPDLSCs 415opportunity of contact between the plasmid and the cytomembrane might be the key to
enhancing the transfection efficiency for hPDLSCs in application of periodontal tissue engi-
neering.
Copyright ª 2015, Association for Dental Sciences of the Republic of China. Published by Else-
vier Taiwan LLC. All rights reserved.Introduction
The application of tissue-engineering methods for the
treatment of periodontal disease has been put forward in
recent years.1,2 Human periodontal ligament stem cells
(hPDLSCs), an undifferentiated stem-cell population pre-
sented in the periodontal ligament (PDL) with self-renewal
and differentiation potential, were proposed as one of the
seed cells for periodontal tissue engineering.3e5 However,
how to successfully induce hPDLSCs to directionally
differentiate into particular cells and form specific tissue,
such as cementum, has been proven to be a great chal-
lenge. In recent years, more and more studies have
demonstrated the truth that some genes transfected to
stem cells interrupt and/or enhance the differentiation of
those cells,6e8 which provided a promising method to ach-
ieve the directional differentiation of hPDLSCs by trans-
fecting helpful DNA into hPDLSCs. However, a few efforts
have been made to research about the possibility of
achieving directionally the differentiation of hPDLSCs by
gene transfection.
Gene-transfection methods can be broadly classified
into viral-vector and nonviral-vector approaches. Although
viral vector has proven to be the most effective gene-
delivery approach, a major obstacle that limits the appli-
cation of viral gene delivery in tissue engineering and
clinical treatment are the potential risks of viral vectors,
such as immunogenicity and oncogenesis from insertional
mutagenesis.9,10 On the contrary, due to its excellent bio-
logical safety, nonviral gene delivery has got more and
more attention in tissue-engineering applications. For
example, Pickard et al11 showed that the magnetic-
nanoparticle-based vector, a new nonviral method, can
safely mediate single/combinatorial gene delivery to neural
precursor/stem cells. But, the transfection efficiency of
the same kinds of nonviral methods will change according
to the different cell types, especially primary cells.12
However, to date, there are very few studies that focus
on the transfection efficiency of introducing foreign DNA
into hPDLSCs by nonviral methods.
Hence, the major purpose of this study was to compare
the transfection efficiency and toxicity of different
nonviral-gene-transfer methods for hPDLSCs to find the
optimal nonviral-gene-delivery method and the best
transfection conditions for hPDLSCs. So far, the nonviral
transfer method mainly includes chemical-based trans-
fection (such as liposome) and particle-based methods
(such as magnetofection). Therefore, Lipofectamine 2000
Reagent (Lipofectamine 2000) and GBfectene-Elite trans-
fection reagent (GBfectene-Elite) as two classicalliposome-based transfection reagents, polyethylenimine
(PEI) as a commonly used cationic polymer transfection
reagent, X-tremeGENE HP DNA Transfection Reagent (X-
tremeGENE) as a transfection reagent for hard-to-transfect
cells, and Magnet-Assisted Transfection (MATra) as a mag-
netofection method were chosen and compared to the
lentiviral vector as the control to transfect hPDLSCs.
Materials and methods
Cell culture
Under the approved guidelines set by the Ethics Commit-
tee, School of Stomatology, Wuhan University, Wuhan,
China the PDL was gently scraped from the impacted and
healthy third molars, and digested in a mixed solution of
3 mg/mL collagenase type I (Sigma-Aldrich, St. Louis, MO,
USA) and 4 mg/mL dispase (Roche, Basel, Switzerland) for 1
hour at 37C. Through a 70 mm strainer, single-cell sus-
pensions (1  104 cells) were seeded into 10 cm petri dishes
containing alpha-minimum essential medium supplemented
with 20% fetal bovine serum, 2mM L-glutamine, 100mM L-
ascorbic acid, 100 mg/mL streptomycin, and 100 U/mL
penicillin (HyClone, Logan, UT, USA), and then incubated at
37C in 5% carbon dioxide.
Flow cytometric analysis
STRO-1, CD44, and CD146 were chosen as surface markers
of hPDLSCs according to the previous studies.3,13,14
Approximately 5  105 cells were collected and incubated
with fluorescein isothiocyanate mouse antihuman CD44 and
CD146 (eBioscience, San Diego, CA, USA) for 40 minutes,
and antihuman STRO-1 (R&D Systems, Minneapolis, MN,
USA) for 1 hour, and then treated for 30 minutes with
fluorescein isothiocyanate goat antimouse secondary anti-
bodies (Bioss, Shanghai, China) at room temperature. Then,
the samples were detected by a flow cytometer (BD Bio-
sciences, San Jose, CA, USA). Cells at passages P3eP5 were
used for the following experiments.
Osteogenic and adipogenic differentiation of
hPDLSCs
About 2e3  104 hPDLSCs were seeded in each well of 24-
well plates, and cultured in a conventional medium. At
90e100% confluence, the medium was changed to an
osteogenic-inducing medium for 4 weeks, which was the
conventional medium supplemented with 10nM
416 Y. Wang et aldexamethasone, 10mM b-glycerophosphate, and 100mM L-
ascorbate. All cells were observed at 7 days, 14 days, 21
days, and 28 days by Alizarin Red S (Sigma-Aldrich)
staining.
About 2e3  104 hPDLSCs were seeded in 24-well plates
and cultured in a conventional medium for 24 hours, and
then cultured with adipogenic-inducing medium (10% fetal
bovine serumealpha-minimum essential medium containing
100nM dexamethasone, 0.5mM isobutylmethylxanthine,
10mM insulin, and 60mM indomethacin) for 4 weeks. In 7
days, 14 days, 21 days, and 28 days, all cells were stained
with fresh Oil Red O solution (Amresco, Solon, OH, USA),
observed under inverted microscopy.Plasmid vectors and transfection reagents
During the following transfection experiments, pGUP6/
GFP/Neo-shNC plasmid purchased from GenePharma
(Shanghai, China) was used to compare the transfection
efficiency.
Moreover, several transfection kits were supplied by
different companies, including (1) Lipofectamine 2000 from
Invitrogen (Carlsbad CA, USA), (2) PEI from GenePharma,
(3) GBfectene-Elite from Genebank Biosciences Inc.
(Zhangjiagang, Jiangsu Province, China), (4) X-tremeGENE
from Roche, and (5) MATra from IBA GmbH (Go¨ttingen,
Germany), and lentiviral vector harboring a green fluores-
cent protein (GFP) gene that was purchased from
GenePharma.Cell transfections
The plasmid encoding GFP was transfected at different
densities of cells according to the protocols of above five
manufacturers, respectively. In order to better evaluate
the optimal transfection dose of each reagent for hPDLSCs,
three groups were designed for every transfection method
according to the transfection-reagent dose: (1) double of
recommended doses on their respective instruction (2),
(2) recommended doses (1), and (3) a half of recom-
mended doses (0.5). All experiments were done in
triplicate.Transfection efficiency
The transfected cells were observed at 24 hours and 48
hours after transfection under a fluorescence microscope,
and photographed. At 48 hours after transfection, the
expression of green fluorescence was observed under the
fluorescence microscope. Firstly, the transfection effi-
ciency was assessed by the ratio of the cell number under
the fluorescence microscope and that under a light micro-
scope as a means of preliminary screening. Secondly, if the
transfection efficiency of the group was estimated higher
than 10%, the cells were collected and analyzed by the flow
cytometer as a way to further evaluate for an accurate
assessment.Results
Isolation and identification of hPDLSCs
During culturing, the single cell (Fig. 1, A1) can be observed
after 2e3 days and single-cell-derived colonies (Fig. 1, A2
and A3) formed after 10e14 days. Fig. 1B shows the positive
expression of STRO-1 (6.5%), CD44 (99%), and CD146 (45%)
for putative hPDLSCs.Differentiation potential of hPDLSCs
After 1 week of induction with the inducing medium, the
cultured hPDLSCs had no obvious change. After 2 weeks of
culture, Alizarin Red-positive mineral deposits gradually
formed (Fig. 1, C1) and increased in the following 3e4
weeks (Fig. 1, C2 and C3).
Moreover, hPDLSCs were capable of undergoing an adi-
pogenic differentiation in the adipogenic-inductive me-
dium. Oil Red O-positive lipid clusters can be observed and
have grown gradually (Fig. 1, C4eC6) after 1 week of cul-
ture. Lipid clusters could not be observed in the control
groups.Assessment of transfection efficiency
Observed results after 24 hours
As shown in Figs. 2e4, within 24 hours after transfection,
green fluorescence expression can be observed in most
groups. Among those methods, the fluorescent quantity of
Lipofectamine 2000 (Fig. 2, Ael) was minimum; the next
were PEI (Fig. 2, MeX), GBfectene-Elite (Fig. 3, Ael), and X-
tremeGENE (Fig. 3, MeX). MATra (Fig. 4) was relatively
more than the others.
Observed results after 48 hours
The expression fluorescence intensity increased signifi-
cantly with increase of time. Roughly like the results after
24 hours, green fluorescence cannot be observed for all
groups of Lipofectamine 2000. However, PEI, GBfectene-
Elite, and X-tremeGENE showed higher transfection effi-
ciencies. But, compared with the lentiviral vector, their
transfection efficiencies were quite low and approximately
< 6%. Besides, the transfection efficiency of MATra was
relatively higher than those four nonviral transfection re-
agents, and reached about 20%. Moreover, the recom-
mended doses (1) showed the best transfection efficiency
among the three different transfection-reagent doses.
Results of flow cytometry
Because the transfection efficiencies of the former four
methods were too low and < 10%, this study only collected
and measured the cells after 48 hours of transfection using
MATra. The 0.8% (gate M2: the fluorescence intensity was >
101 of FL1-H) and 0.02% untransfected cells (gate M3: the
fluorescence intensity was > 102 of FL1-H) were used to
gate for weakly GFP-positive cells and GFP-positive cells,
respectively. The amount of GFP weak positive cells and
Figure 1 Isolation and identification of hPDLSCs. After hPDLSCs were seeded at low density, a single cell can be observed (A1)
and single-cell-derived colonies formed gradually (A2, A3). Flow-cytometry analysis showed that hPDLSCs expressed STRO-1 (B1),
CD44 (B2), and CD146 (B3). After induction for 4 weeks, mineralized deposits were formed (C1eC3) and the lipid clusters (arrows)
could be observed (C4eC6). C1eC3 were Alizarin Red staining and C4eC6 were Oil Red O staining.
Various nonviral vectors for transfecting hPDLSCs 417GFP positive cells of MATra achieved 90e98% and 1e11%,
respectively (Fig. 5 B -D).
Assessment of cytotoxicity
With the increase of cytotoxicity, cell morphology became
irregular and cell mortality also increased. According to the
cell morphology and cell-death rate in the bright-field
pictures (Figs. 2e4), cell toxicity was getting higher with
the increase of the dose for lipofectamine 2000, PEI,
GBfectene-Elite, X-tremeGENE. The cytotoxicity of Lip-
ofectamine 2000, PEI, and GBfectene-Elite was stronger
than that of X-tremeGENE and MATra.Discussion
According to the classical methods of culturing hPDLSCs
from Mrozik et al,15 hPDLSCs were successfully isolated and
identified in this study, which also expressed STRO-1/CD44/
CD146 and had the potential of multipotent differentiation.
The theory that some transferred genes can interrupt
and/or enhance the differentiation of stem cells has been
confirmed by many studies. For instance, the transfection
of bone morphogenetic protein/vascular endothelial
growth factor and SRY (sex determining region Y)-box 9
(SOX9) into human mesenchymal stem cells has been
affirmed with strong synergistic responses in bone
Figure 2 Assessment of transfection efficiencies of Lipofectamine 2000 and PEI. The fluorescence views of GFP gene expression
of 24 hours and 48 hours after transfection by different doses of Lipofectamine 2000 (AeL) and PEI (MeX). Magnification is 10.
418 Y. Wang et alregeneration and cartilage regeneration.16e18 Therefore,
some scholars proposed that it is useful for forming a PDL-
like tissue to transfect some genes into the hPDLSCs.19
Ramseier et al20 and Jin et al21 reported that rat dermal
fibroblast with modified bone morphogenetic protein-7 or
platelet-derived growth factor subunit B genes could
stimulate the bioactivities of cells, and obtained the
improved periodontal regeneration. However, almost all
studies were using viral transfection methods. Owing to
their superiorities, such as relative biological safety, the
ability to transfer large-size genes, and less toxicity, the
nonviral methods will be likely to replace the viral methods
from the general trend.
However, the transfection efficiency of each nonviral
method is highly dependent on the cell type to betransfected. On the one hand, using the same methods, the
transfection efficiency will vary greatly because of the
different cell types. For instance, transfecting by Lip-
ofectamine 2000, the transfection efficiencies of pig fetal
fibroblasts, pig tracheal epithelial cells, and human
tracheal epithelial cells were 28%, 30%, and 14%, respec-
tively. With PEI, the transfection efficiencies of the afore-
mentioned cells were 32%, 10%, and 8%, respectively.22 On
the other hand, for the same cells, the transfection effi-
ciency also differs for different methods. For car-
diomyocytes, Lipofectamine 2000 was the most effective
nonviral method compared with FuGENE 6, Lipofectamine
PLUS, LipoGen, and nucleofector techniques.23 At present,
there are very few studies that show which kind of nonviral
transfection method is best for hPDLSCs. Therefore, this
Figure 3 Assessment of transfection efficiencies of GBfectene-Elite and X-tremeGENE. The fluorescence views of GFP gene
expression of 24 hours and 48 hours after transfection by different doses of GBfectene-Elite (AeL) and X-tremeGENE (MeX).
Magnification is 10.
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the parameters of nonviral vectors transferred to hPDLSCs
for basic research and potential clinical uses.
For the nonviral methods, Lipofectamine 2000, a clas-
sical cationic lipid, allows high transfection efficiencies and
protein expression levels for the kinds of cells in theory.
But, it has little effect on transfecting genes to hPDLSCs.
GBfectene-Elite is a sterile solution of a cationic liposome
in water. Although designed for commonly used and hard-
to-transfect cells and cell lines, the transfection efficiency
of GBfectene-Elite for hPDLSCs was < 6% in this study.
Lipofectamine 2000 and GBfectene-Elite belong to cationic
lipids in essence. The suspected reason for that ineffec-
tiveness was that there are unknown anionic elements,existing on the surface of or surrounding hPDLSC mem-
brane, interrupting the effect of cationic lipids. This was
supported by Ruponen et al24 who confirmed that the
transfection efficiencies of several commonly used cationic
lipid formulations can be obstructed by anionic heparin
sulfate. PEI, a highly charged organic polymer, is widely
used in nonviral gene delivery.25e27 In this study, the
transfection efficiency of PEI for hPDLSCs (about 3%) was
also disappointing. The reason may again be the interaction
between the positively charged polymers and the nega-
tively charged element within hPDLSCs. Lu et al28 reported
that cationic polymers did not improve the transfection
efficiency in myoblasts because of the interaction between
the positively charged polymers and the negatively charged
Figure 4 Assessment of transfection efficiency of MATra. The fluorescence views of GFP gene expression of 24 hours and 48 hours
after transfection by different doses of MATra (AeL). Magnification is 10.
Figure 5 The GFP expression detected by flow cytometry. The flow cytometry was used to analyze the GFP expression of (A)
untransfected and transfected cells by (B) 0.5, (C) 1, and (D) 2 of MATra.
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Finally, X-tremeGENE is a nonliposomal, multicomponent
reagent proven to efficiently transfect a broad spectrum of
cell types, especially hardly transfected cells. Because the
special component of X-tremeGENE is not exposed, the
mechanism of low transfection efficiency is not clear. It was
hypothesized that the low transfection efficiency may be
related to the special composition. Above all, further re-
searches are necessary to explain the definite mechanism
of the low transfection efficiency.
MATra is a new, fast, and highly efficient method to
transfect the cultured cells. Firstly, nucleic acids are
associated with specific magnetic nanoparticles. The full
nucleic acid is then drawn toward and delivered into the
target cells, leading to an efficient transfection by mag-
netic force without causing chromosomal damage like
other transfection technologies do. In a previous study,
Albukhaty et al29 reported that the transfection efficiency
of rat neural stem cells using magnetic nanoparticles could
achieve 18%. This also demonstrates that magnetofection
played a role in the transfection of stem cells. In this study,
the transfection efficiency of MATra was also higher than
the other four nonviral methods. One possible reason was
that the transfection mechanisms of MATra did not involve
an interaction between positive and negative charges.
Therefore, the transfection efficiency did not suffer from
any barrier of negatively charged elements. Another sup-
posed reason was that the magnet considerably increased
the opportunity of contact between the DNA/MATra com-
plex and the cytomembrane, which enhanced the cytoph-
agy. As shown in Fig. 5, the weakly GFP-positive cells
achieved 90e98% because the flow cytometer was more
sensitive than a human naked eye. But, their fluorescence
intensity was mostly in the area of 101e102 of FL1-H (low
fluorescence intensity). Therefore, the relatively high
weakly-GFP-positive-cell ratio of MATra indicated that this
method could be used in those researches to discuss the
biological effect of the existence or inexistence of some
genes, such as a certain promoter, which could launch a
series of reactions once it existed. However, since the
percentage of the GFP-positive cell was not high (only 11%)
and the fluorescence intensities of the weakly positive cell
were mostly low (101e102), which were the same as the
GFP expression of the fluorescence microscope, it should
be thought twice before using this nonviral vector for gene
delivery if the study was designed to explore the effect of
the different quantities of the transfected gene
expression.
In conclusion, the transfection efficiency of hPDLSCs
with magnetofection was higher than the other four
nonviral transfection reagents in this study. However, the
low transfection efficiency of nonviral vectors still cannot
meet the requirements of the high-efficiency periodontal
tissue regeneration. Therefore, further research should be
done to confirm and overcome the barrier, for example,
whether an unknown anionic element interrupts the
transfection efficiency of the nonviral transfection for
hPDLSCs. Avoiding the anionic element interrupt and
increasing the opportunity of contact between plasmid with
cytomembrane might be the key to enhancing the trans-
fection efficiency for hPDLSCs. With continuous improve-
ments, new nonviral transfer techniques are very likely tobecome a useful vector for delivering genes into hPDLSCs,
and then promote high-efficiency periodontal regeneration.Conflicts of interest
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